Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yutaka Yamamoto

Showing results (1-10 of 381) with videos related to

Pageof 39
Sort By:
Cancers|March 28, 2026
Overcoming Trastuzumab-Pertuzumab Resistance and Optimizing Sequential Anti-HER2 Therapy in HER2-Positive Metastatic Breast CancerYutaka Yamamoto
International Journal of Clinical Oncology|October 24, 2008
Safety profiles of aromatase inhibitors and selective estrogen-receptor modulators in the treatment of early breast cancerYutaka Yamamoto, Hirotaka Iwase
International Journal of Clinical Oncology|February 13, 2015
Clinical benefit of sequential use of endocrine therapies for metastatic breast cancerHirotaka Iwase, Yutaka Yamamoto
International Journal of Clinical Oncology|July 16, 2010
Clinicopathological features and treatment strategy for triple-negative breast cancerYutaka Yamamoto, Hirotaka Iwase
Surgery Today|December 12, 2012
Visualization of diffusion of the drug solution during aluminum potassium tannic acid injection therapy: a pilot studyYutaka Yamamoto, Mitsuharu Miwa
Genes|July 27, 2022
Development of Transformation for Genome Editing of an Emerging Model OrganismYutaka Yamamoto, Susan A Gerbi
Chromosoma|July 14, 2018
Making ends meet: targeted integration of DNA fragments by genome editingYutaka Yamamoto, Susan A Gerbi
Genes|July 29, 2023
Correction: Yamamoto, Y.; Gerbi, S.A. Development of Transformation for Genome Editing of an Emerging Model Organism. <i>Genes</i> 2022, <i>13</i>, 1108Yutaka Yamamoto, Susan A Gerbi
Congenital Anomalies|May 29, 2010
Cerebro-costo-mandibular syndrome: prognosis and proposal for classificationHiroyuki Nagasawa, Yutaka Yamamoto, Yoshinori Kohno
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 18, 2005
[Experience of high-dose toremifene treatment for postmenopausal women with metastatic breast cancer]Yutaka Yamamoto, Teru Kawazoe, Hirotaka Iwase
Pageof 39

Showing results (1-10 of 381) with videos related to

Sort By:
Pageof 39
Cancers|March 28, 2026
Overcoming Trastuzumab-Pertuzumab Resistance and Optimizing Sequential Anti-HER2 Therapy in HER2-Positive Metastatic Breast CancerYutaka Yamamoto
International Journal of Clinical Oncology|October 24, 2008
Safety profiles of aromatase inhibitors and selective estrogen-receptor modulators in the treatment of early breast cancerYutaka Yamamoto, Hirotaka Iwase
International Journal of Clinical Oncology|February 13, 2015
Clinical benefit of sequential use of endocrine therapies for metastatic breast cancerHirotaka Iwase, Yutaka Yamamoto
International Journal of Clinical Oncology|July 16, 2010
Clinicopathological features and treatment strategy for triple-negative breast cancerYutaka Yamamoto, Hirotaka Iwase
Surgery Today|December 12, 2012
Visualization of diffusion of the drug solution during aluminum potassium tannic acid injection therapy: a pilot studyYutaka Yamamoto, Mitsuharu Miwa
Genes|July 27, 2022
Development of Transformation for Genome Editing of an Emerging Model OrganismYutaka Yamamoto, Susan A Gerbi
Chromosoma|July 14, 2018
Making ends meet: targeted integration of DNA fragments by genome editingYutaka Yamamoto, Susan A Gerbi
Genes|July 29, 2023
Correction: Yamamoto, Y.; Gerbi, S.A. Development of Transformation for Genome Editing of an Emerging Model Organism. <i>Genes</i> 2022, <i>13</i>, 1108Yutaka Yamamoto, Susan A Gerbi
Congenital Anomalies|May 29, 2010
Cerebro-costo-mandibular syndrome: prognosis and proposal for classificationHiroyuki Nagasawa, Yutaka Yamamoto, Yoshinori Kohno
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 18, 2005
[Experience of high-dose toremifene treatment for postmenopausal women with metastatic breast cancer]Yutaka Yamamoto, Teru Kawazoe, Hirotaka Iwase
Pageof 39